FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:1922-1925 November 2, 2006 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Birks, E. J. PubMed Citation

Heart failure is increasing in incidence and prevalence, is expensive to treat, and is associated with substantial morbidity and mortality.¹ In the nomenclature of the guidelines of the American Heart Association and the American College of Cardiology, the majority of patients with heart failure are classified as having stage C heart failure, characterized by structural heart disease that is or has been symptomatic.² Numerous drugs (e.g., angiotensin converting–enzyme [ACE] inhibitors or angiotensin-receptor blockers, beta-blockers, and aldosterone blockers) and electrophysiological devices may temporarily halt, slow, or even reverse the pathophysiological processes in patients with stage C heart failure. Reversion of the . . . [Full Text of this Article]

Source Information

From the Utah Transplantation Affiliated Hospitals (UTAH) Cardiac Transplant Program (D.G.R., A.G.K.), the Division of Cardiology, LDS Hospital (D.G.R., A.G.K.), and the Division of Cardiology, University of Utah School of Medicine (D.G.R.) — all in Salt Lake City.

This article has been cited by other articles:

• TERRACCIANO, C. M. N., KOBAN, M. U., SOPPA, G. K., SIEDLECKA, U., LEE, J., STAGG, M. A., YACOUB, M. H. (2007). The Role of the Cardiac Na+/Ca2+ Exchanger in Reverse Remodeling: Relevance for LVAD-Recovery. Ann. N. Y. Acad. Sci. 1099: 349-360 [Abstract] [Full Text]  
• (2006). Can an LVAD plus Drugs Reverse Advanced Systolic Heart Failure?. Journal Watch Cardiology 2006: 2-2 [Full Text]